Cargando…
Three tumor markers for improved efficacy in the management of patients with malignant pleural mesothelioma
BACKGROUND: Evaluation of tumor markers may facilitate follow-up of malignant pleural mesothelioma (MPM). We aimed was to evaluate the value of tumor markers for monitoring and predicting recurrence in patients with MPM. METHODS: In total, 152 patients who underwent curative-intent surgery after ind...
Autores principales: | Nakamura, Akifumi, Takuwa, Teruhisa, Hashimoto, Masaki, Kuroda, Ayumi, Nakamichi, Toru, Matsumoto, Seiji, Kondo, Nobuyuki, Kijima, Takashi, Hasegawa, Seiki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711396/ https://www.ncbi.nlm.nih.gov/pubmed/33282372 http://dx.doi.org/10.21037/jtd-20-1910 |
Ejemplares similares
-
Incidence and Risk Factors of Chest Wall Metastasis at Biopsy Sites in Patients with Malignant Pleural Mesothelioma
por: Hashimoto, Masaki, et al.
Publicado: (2022) -
Response to Immune Checkpoint Inhibitor Therapy in Patients with Unresectable Recurrent Malignant Pleural Mesothelioma Shown by FDG-PET and CT
por: Kitajima, Kazuhiro, et al.
Publicado: (2021) -
Relationship Between Physical Function and Health Utility in Patients Undergoing Surgical Treatment for Malignant Pleural Mesothelioma
por: Tanaka, Takashi, et al.
Publicado: (2021) -
Clinical utility of FDG-PET/CT for post-surgery surveillance of malignant pleural mesothelioma – Comparison with contrast-enhanced CT
por: Kitajima, Kazuhiro, et al.
Publicado: (2019) -
Deep learning with deep convolutional neural network using FDG-PET/CT for malignant pleural mesothelioma diagnosis
por: Kitajima, Kazuhiro, et al.
Publicado: (2021)